2-25161052-GA-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BS1_SupportingBS2
The NM_000939.4(POMC):c.*28del variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00152 in 1,613,858 control chromosomes in the GnomAD database, including 2 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0010 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0016 ( 2 hom. )
Consequence
POMC
NM_000939.4 3_prime_UTR
NM_000939.4 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -1.23
Genes affected
POMC (HGNC:9201): (proopiomelanocortin) This gene encodes a preproprotein that undergoes extensive, tissue-specific, post-translational processing via cleavage by subtilisin-like enzymes known as prohormone convertases. There are eight potential cleavage sites within the preproprotein and, depending on tissue type and the available convertases, processing may yield as many as ten biologically active peptides involved in diverse cellular functions. The encoded protein is synthesized mainly in corticotroph cells of the anterior pituitary where four cleavage sites are used; adrenocorticotrophin, essential for normal steroidogenesis and the maintenance of normal adrenal weight, and lipotropin beta are the major end products. In other tissues, including the hypothalamus, placenta, and epithelium, all cleavage sites may be used, giving rise to peptides with roles in pain and energy homeostasis, melanocyte stimulation, and immune modulation. These include several distinct melanotropins, lipotropins, and endorphins that are contained within the adrenocorticotrophin and beta-lipotropin peptides. The antimicrobial melanotropin alpha peptide exhibits antibacterial and antifungal activity. Mutations in this gene have been associated with early onset obesity, adrenal insufficiency, and red hair pigmentation. Alternatively spliced transcript variants encoding the same protein have been described. [provided by RefSeq, Jan 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.001 (153/152342) while in subpopulation NFE AF= 0.00201 (137/68030). AF 95% confidence interval is 0.00174. There are 0 homozygotes in gnomad4. There are 58 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAdExome4 at 2 SD gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
POMC | NM_000939.4 | c.*28del | 3_prime_UTR_variant | 3/3 | ENST00000395826.7 | NP_000930.1 | ||
POMC | NM_001035256.3 | c.*28del | 3_prime_UTR_variant | 4/4 | NP_001030333.1 | |||
POMC | NM_001319204.2 | c.*28del | 3_prime_UTR_variant | 4/4 | NP_001306133.1 | |||
POMC | NM_001319205.2 | c.*28del | 3_prime_UTR_variant | 3/3 | NP_001306134.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
POMC | ENST00000395826.7 | c.*28del | 3_prime_UTR_variant | 3/3 | 2 | NM_000939.4 | ENSP00000379170 | P1 | ||
POMC | ENST00000405623.5 | c.*28del | 3_prime_UTR_variant | 3/3 | 1 | ENSP00000384092 | P1 | |||
POMC | ENST00000264708.7 | c.*28del | 3_prime_UTR_variant | 4/4 | 2 | ENSP00000264708 | P1 | |||
POMC | ENST00000380794.5 | c.*28del | 3_prime_UTR_variant | 4/4 | 2 | ENSP00000370171 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00101 AC: 153AN: 152224Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
153
AN:
152224
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000915 AC: 228AN: 249178Hom.: 0 AF XY: 0.000991 AC XY: 134AN XY: 135280
GnomAD3 exomes
AF:
AC:
228
AN:
249178
Hom.:
AF XY:
AC XY:
134
AN XY:
135280
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00157 AC: 2298AN: 1461516Hom.: 2 Cov.: 32 AF XY: 0.00149 AC XY: 1081AN XY: 727080
GnomAD4 exome
AF:
AC:
2298
AN:
1461516
Hom.:
Cov.:
32
AF XY:
AC XY:
1081
AN XY:
727080
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00100 AC: 153AN: 152342Hom.: 0 Cov.: 33 AF XY: 0.000779 AC XY: 58AN XY: 74500
GnomAD4 genome
AF:
AC:
153
AN:
152342
Hom.:
Cov.:
33
AF XY:
AC XY:
58
AN XY:
74500
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Monogenic Non-Syndromic Obesity Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Obesity due to pro-opiomelanocortin deficiency Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at